本期内容提示:
1、美股大盘跌跌不休,是否有抄底机会?$纳指100ETF-Invesco(QQQ)$
2、$Solid Biosciences(SLDB)、$Valneva SE(VALN)增发,是否有机会跟仓?
3、$贝壳(BEKE)$ 、$创新ETF-ARK(ARKK)$ 、$Twitter(TWTR)、$中概互联网指数ETF-KraneShares...查看全文
不入流资讯11-15 09:50
$Solid Biosciences(SLDB)$ Solid Biosciences +38% as FDA clears IND for muscular dystrophy therapy查看全文
Solid Biosciences(SLDB)11-15 21:35
$Solid Biosciences(SLDB)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001193125-23-277552 Act: 34 Size: 176 KB 网页链接查看全文
Solid Biosciences(SLDB)10-21 04:25
$Solid Biosciences(SLDB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-23-054388 Size: 7 KB 网页链接查看全文
Solid Biosciences(SLDB)10-21 04:25
$Solid Biosciences(SLDB)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000950170-23-054381 Size: 15 KB 网页链接查看全文
Solid Biosciences(SLDB)10-06 03:15
$Solid Biosciences(SLDB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-23-052171 Size: 7 KB 网页链接查看全文
Solid Biosciences(SLDB)09-07 04:45
$Solid Biosciences(SLDB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-23-046760 Size: 9 KB 网页链接查看全文
美股滚雪球01-12 12:19
$Solid Biosciences(SLDB)$ 和Phlox Therapeutics达成战略合作,开发针对遗传性心脏病的精准药物。这项研究合作将针对一种严重的遗传性扩张型心肌病(DCM)。
这项战略合作将整合Solid的载体生物学、制造能力和药物开发经验,以及Phlox在遗传心肌病和RNA治疗方面的专业知识。
两家公司表示,...查看全文
牛唐2022-10-03 15:50
医药板块速评(2022.09.30)
本期内容提示:
1、美股大盘跌跌不休,是否有抄底机会?$纳指100ETF-Invesco(QQQ)$
2、$Solid Biosciences(SLDB)、$Valneva SE(VALN)增发,是否有机会跟仓?
3、$贝壳(BEKE)$ 、$创新ETF-ARK(ARKK)$ 、$Twitter(TWTR)、$中概互联网指数ETF-KraneShares...查看全文
美股滚雪球2022-10-02 22:24
$Solid Biosciences(SLDB)$ 宣布收购基因治疗公司AavantiBio,旨在推进一系列神经肌肉和心脏项目,预计四季度完成合并。
交易完成后,AavantiBio现任首席执行官Bo Cumbo将担任Solid Biosciences的总裁兼首席执行官。
为支持此次收购,SLDB已与一些选定的机构投资者和合格投资者达成了一项...查看全文
$Solid Biosciences(SLDB)$ DEF 14A - Other definitive proxy statements Filed: 2019-05-03 AccNo: 0001140361-19-008386 Size: 3 MB 网页链接
$Solid Biosciences(SLDB)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2019-05-03 AccNo: 0001140361-19-008388 Size: 370 KB 网页链接
$Solid Biosciences(SLDB)$ EFFECT - Notice of Effectiveness Filed: 2019-03-19 AccNo: 9999999995-19-000469 Size: 1 KB 网页链接
$Solid Biosciences(SLDB)$ 8-K - Current report Filed: 2019-03-13 AccNo: 0001193125-19-072676 Size: 92 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Solid Biosciences(SLDB)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-03-13 AccNo: 0001564590-19-007462 Size: 12 MB 网页链接
$Solid Biosciences(SLDB)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2019-03-13 AccNo: 0001193125-19-072709 Size: 1 MB 网页链接
$Solid Biosciences(SLDB)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-03-06 AccNo: 0001193125-19-065709 Size: 90 KB 网页链接
$Solid Biosciences(SLDB)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-14 AccNo: 0001193125-19-040820 Size: 86 KB 网页链接
$Solid Biosciences(SLDB)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-14 AccNo: 0001193125-19-040941 Size: 63 KB 网页链接
$Solid Biosciences(SLDB)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-14 AccNo: 0000875045-19-000009 Size: 75 KB 网页链接